Archives

This SIGN guideline was published in January 2019 and is expected to be of interest to those involved in the assessment and diagnosis of people at risk of fetal alcohol spectrum disorder (FASD), [...]

Stopping the over-medication of children and young people with a learning disability, autism or both (STOMP) and supporting treatment and appropriate medication in paediatrics (STAMP). This [...]

Cariprazine (Reagila) is a new second-generation antipsychotic which is licensed to treat schizophrenia in adults (over 18 years). It is only available as an oral capsule and is presented in [...]

Public Health England has produced a suicide prevention profile in order to help develop understanding at a local level and support an intelligence-driven approach to suicide prevention. It [...]

This NICE quality standard was published in February 2019 and covers the diagnosis and management of cataracts, glaucoma and age‑related macular degeneration (AMD) and the prevention of sight [...]

I spent the two first weeks of October 2018 volunteering with a Basque NGO called Salvamento Marítimo Humanitario (SMH) – a humanitarian rescue association in the Greek island of Chios, [...]

This medicines evidence commentary document was published in February 2019 and covers the incidence, management and risk of suicide in over 65s with a history of self-harm. A UK study found that [...]

The Food Standards Agency (FSA) has launched a publicity campaign to warn consumers about the health risks of using dietary products commonly known as ‘fat burners’ which are mainly obtained via [...]

What is the current risk of shortages for medicines and medical products due to Brexit? Should there be a no-deal Brexit, then there may be shortages of some medicines and other products due to [...]

The summer season is approaching and although there are many benefits to going outside and enjoying the weather, it’s important to ensure you and your patients are always properly protected [...]